Buy Meqsel Trametinib 2mg Injection Online from GlobMedIndia – The Medicine Exporter India.

Meqsel Trametinib 2mg Injection

Meqsel Trametinib 2mg Injection is an anti-cancer medication that contains Trametinib as its active ingredient. It belongs to a class of targeted therapy drugs known as MEK inhibitors. This medicine is primarily used in the treatment of certain types of cancer, especially melanoma and non-small cell lung cancer (NSCLC) with specific genetic mutations such as BRAF mutations.

Trametinib works by blocking the activity of MEK proteins in cancer cells, thereby slowing down or stopping the growth and spread of cancer. It is often used alone or in combination with other targeted therapies to improve treatment outcomes.

📞 Contact Details to Place Order

💬 WhatsApp: +91 9730316395
📞 Phone: +91 9730316395
📧 Email: info@globmedindia.com
🌐 Website: https://globmedindia.com

Composition and Content

Active Ingredient: Trametinib Dimethyl Sulfoxide equivalent to Trametinib 2 mg
Form: Injection / targeted therapy formulation
Class: MEK inhibitor (Mitogen-Activated Protein Kinase inhibitor)

How to Use

Meqsel Trametinib should be administered only under the supervision of a qualified oncologist.
It is usually given as per prescribed treatment cycles depending on the type and stage of cancer.
The dosage and duration vary based on patient condition, body response, and combination therapy (if any).
Do not self-administer unless instructed by a healthcare professional.

Dosage

Standard dosage is determined by the doctor.
Typically aligned with 2 mg daily dosing protocol (if oral equivalent is considered), but injection use depends on clinical protocols.
Follow strict medical guidance for dosage adjustments.

Uses

Meqsel Trametinib 2mg Injection is used in the treatment of:

Metastatic melanoma (BRAF V600 mutation-positive)
Non-small cell lung cancer (NSCLC)
Thyroid cancer (in selected cases)
Other cancers as prescribed in targeted therapy regimens

Treatments & Mechanism

Works by blocking MEK1 and MEK2 enzymes, which are part of the MAPK pathway.
Helps in stopping tumor cell proliferation.
Often combined with BRAF inhibitors (like Dabrafenib) for enhanced effectiveness.

Advantages

Targeted therapy with fewer effects on healthy cells
Improves survival rate in mutation-specific cancers
Can be used in combination therapy for better outcomes
Precision-based treatment approach

Storage Conditions

Store at 2°C to 8°C (refrigerated conditions)
Protect from light and moisture
Do not freeze
Keep out of reach of children

Alternative Indian Brands for Trametinib

Some alternative brands or equivalents available in India include:

Trametinib Tablets (Generic versions)
Mekinist (by Novartis – widely used global brand)
Other oncology suppliers may offer generic Trametinib formulations

(Note: Availability of injection form may vary; consult supplier or oncologist.)